Geneos Wealth Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Geneos Wealth Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-350	Closed	-$1K	–	3062
2020 Q3	$1K	Hold	350	–	–	﹤0.01%	2622
2020 Q2	$1K	Buy	+350	New	+$1.57K	﹤0.01%	2557
2020 Q1	–	Sell	-500	Closed	-$3K	–	2662
2019 Q4	$3K	Sell	500 -300	-38%	-$1.76K	﹤0.01%	2342
2019 Q3	$3K	Hold	800	–	–	﹤0.01%	2272
2019 Q2	$3K	Hold	800	–	–	﹤0.01%	2285
2019 Q1	$4K	Hold	800	–	–	﹤0.01%	2128
2018 Q4	$2K	Hold	800	–	–	﹤0.01%	2266
2018 Q3	$2K	Hold	800	–	–	﹤0.01%	2308
2018 Q2	$2K	Hold	800	–	–	﹤0.01%	2159
2018 Q1	$1K	Hold	800	–	–	﹤0.01%	2159
2017 Q4	$2K	Hold	800	–	–	﹤0.01%	2075
2017 Q3	$2K	Buy	800 +300	+60%	+$914	﹤0.01%	2020
2017 Q2	$1K	Buy	+500	New	+$1.05K	﹤0.01%	2063
2016 Q4	–	Sell	-500	Closed	-$1K	–	2103
2016 Q3	$1K	Hold	500	–	–	﹤0.01%	1967
2016 Q2	$1K	Hold	500	–	–	﹤0.01%	1798
2016 Q1	$1K	Buy	+500	New	+$1.85K	﹤0.01%	1782

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneos Wealth Management's BDSI Position: Q4 2020 in Review

Geneos Wealth Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 350 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in BDSI in Q1 2016 and held it in 16 quarters. The position peaked at $4K in Q1 2019. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

Geneos Wealth Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
Geneos Wealth Management sold 350 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $1K.
Geneos Wealth Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2016 and held it in 16 quarters.
Geneos Wealth Management's BioDelivery Sciences International, Inc. position peaked at $4K in Q1 2019.
145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.